HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gelbard, A. S. Articles by Laughlin, J. S. Search for Related Content PubMed PubMed Citation Articles by Gelbard, A. S. Articles by Laughlin, J. S.

Imaging of the Human Heart after Administration of L-(N-13)Glutamate

Memorial Sloan-Kettering Cancer Center, New York, New York

Correspondence: For reprints contact: Alan S. Gelbard, Biophysics Laboratory, Memorial Sloan-Kettering Cancer Ctr., 1275 York Ave., New York, NY 10021.

ABSTRACT

In normal volunteers and cancer patients, studies using L-(N-13)glutamate as an imaging agent showed localization of N-13 activity in the heart. Other organs that were well visualized include the liver, pancreas, and salivary glands. In ten subjects the average myocardial uptake after intravenous injection of labeled glutamate was (5.7 ± 0.39)% (s.e.m.) of injected dose, as determined by a quantitative scanning system. The concentration of N-13 activity in the human heart could not be predicted from previous studies involving myocardial uptake in dogs and rodents after administration of L-(N-13)glutamate.